Improving Access to Lupus Nephritis Treatment: Strategies and Resources

Author(s):

Ryan Haumschild, PharmD, MS, MBA,Jorge Larranaga, MD

Key Takeaways

Financial constraints and limited healthcare access are significant barriers to timely lupus nephritis treatment, affecting patient outcomes.
Patient assistance programs, educational initiatives, and support groups are crucial resources for facilitating access to lupus nephritis care.
Payers are adopting strategies like coverage for novel therapies and value-based care models to support timely access to lupus nephritis treatment.

Panelists discuss the challenges patients face in accessing lupus nephritis treatment and the resources available to support timely access, including how payers are facilitating care.

EP: 1.Understanding the Clinical Burden and Prevalence of Lupus Nephritis

EP: 2.Cost Drivers in Lupus Nephritis

EP: 3.Urgency to Treat in Lupus Nephritis: Goals of Therapy and Early Diagnosis Strategies

EP: 4.Guideline Updates in Lupus Nephritis: Impacts on Clinical Decision-Making

EP: 5.Tailoring Lupus Nephritis Treatment: Key Considerations and Specialist Approaches

EP: 6.Belimumab and Voclosporin: Clinical Insights and Payer Evaluations in Lupus Nephritis

Now Viewing

EP: 7.Improving Access to Lupus Nephritis Treatment: Strategies and Resources

EP: 8.Lupus Nephritis Management: Monitoring Strategies and Long-Term Study Results

EP: 9.Collaborating for Better Care: Healthcare Providers and Payers in Lupus Nephritis

EP: 10.From Guidelines to Practice: Advancing Lupus Nephritis Treatment

EP: 11.Looking Ahead: Anticipating Changes in Lupus Guidelines and Clinical Practice

What challenges or barriers do patients face when accessing lupus nephritis (LN) treatment, and what resources are available to support timely access to treatment?
How are payers supporting timely access to care in LN?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!